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Although obesity is a global epidemic that affects every socio-economic class, little is 
available in the literature on the status of the syndrome in Africa. This literature 
review was therefore written in order to highlight the causes, effects and potential 
mitigation measures of the syndrome with particular interest on the status of the 
condition in Africa. Obesity results from an incorrect energy balance leading to an 
increased store of energy, mainly as fat. The major factors that contribute to obesity 
include over-nutrition, physical inactivity, change of dietary habits, modernization, 
consumption of high fat, high carbohydrate foods, urbanization and in a minority of 
patients a physical condition or metabolic disturbance. Body mass index (BMI) is 
currently being used by competent authorities as an index of obesity. BMI 
differentiates classes of obesity, with class I, II and III being identified with BMI of 
≥30 but <35, ≥35 but <40, and ≥40, respectively. A BMI of 18.5-25 is regarded as 
normal. However, it is sometimes difficult to differentiate obesity due to excess fat 
deposition and that due to muscle atrophy. Also, current procedures for estimating 
body fat percentage are not as accurate as they should and often give different results. 
Despite women tending to be more obese than men, they are less prone to 
hypertension, heart disease and type 2 diabetes than men before they reach 
menopause due to their fat deposition being predominantly sub-cutaneous rather than 
abdominal. In 2010, the WHO estimated that about 1.4 billion adults were overweight 
and obese, but 300-400 million were obese. The defining metabolic changes in 
obesity are decreased glucose tolerance, decreased sensitivity to insulin, 
hyperinsulinemia and reduced life expectancy. Obesity can be treated by restricting 
food intake and engaging in regular physical exercises. Other measures include the 
use of anorectic drugs and various forms of jejunoileostomy. Obesity is a controllable 
behavioural disorder, with regular exercise and sensible eating being the best ways to 
regulate body fat percentage and maintain a healthy body weight. As it is difficult to 
treat obesity, efforts should be directed towards prevention in order to keep it in 
check.  
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INTRODUCTION – Defining and Assessing Obesity 
 
Obesity is a state in which an excess of fat has accumulated in the body. Assessment 
is usually done by weighing the patient and relating weight to height. The weight (W) 
in kilograms over height (H) in meters2 (H2) gives an index commonly referred to as 
the body mass index (BMI). The measure of BMI is used to differentiate classes of 
obesity in patients. Class I, II and III obesity are identified with BMI of ≥30 but <35, 
≥35 but <40, and ≥40, respectively [1]. A person with a BMI <25 is not obese 
according to current classification [2]. However, the above definition of obesity does 
not distinguish between overweight due to obesity and muscle hypertrophy. Also, 
although obesity is a simple index of weight-for-height that is commonly used to 
classify overweight and obesity in adults, it may not correspond to the same degree of 
fatness in different individuals [3]. Despite BMI being a rough guide, it is 
nevertheless the most useful population-level measure of overweight and obesity as it 
is the same for both sexes and for all ages of adults. However, one study found that 
BMI underestimates obesity especially in women with high leptin levels (>30 ng/mL), 
although the accuracy can be improved by using the revised leptin levels to estimate 
body fat percentage when dual-energy X-ray absorptiometry (DEXA) is available [4].  
Obesity and overweight are the fifth leading causes of global deaths [3]. The US 
National Institutes of Health regards BMI of 25.0-29.9 as overweight, and strongly 
discourages having a BMI less than 18.5 (underweight) [5]. It defines obesity as BMI 
>30, and overweight in women being 27.3% or more than the normal BMI for their 
height and weight, while for men, it is 27.8% or more than the normal BMI for men. 
Computed tomography (CT) scans and hormonal blood tests seem to give more 
accurate estimates of visceral fat than waistline measurements [1]. However, one 
study found that CT scanners may be imprecise for visceral fat estimation unless a 
flexible attenuation range is used for determining abdominal fat distribution [6].   
Also, another study found that anthropometric measurements and visceral fat tissue 
measurements such as ultrasonography and bioimpedance analysis (BIA) exhibit 
differences with respect to compliance with CT results in visceral fat tissue 
measurements by gender and BMI [7]. These observations point to the need to find 
more accurate methods and procedures for estimating obesity in individuals. Good 
comparisons between methods for measurement of obesity are also needed. Some 
recent methods which are being tried include improved CT radiology, dual energy X-
ray absorptiometry (DEXA), bioimpedance analysis (BIA) and their combinations [6, 
8].  
 
GLOBAL TRENDS OF OBESITY 
 
It was not until the 20th century that the WHO finally recognized obesity as a global 
epidemic.  As of 2010, the WHO estimated that at about 300-400 million adults were 
obese, while 1 billion were overweight, with higher rates for both conditions among 
women than men [9]. The rate of obesity also increases with age up to 50 or 60 years. 
Once considered a problem of rich countries, obesity rates are increasing worldwide, 
with developing countries experiencing unprecedented increases. A new word 
describing the global nature of the epidemic has been coined-“globesity”. The 
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region where obesity is not common is sub-Saharan Africa [9], but there is an upward 
trend.   
 
A WHO/PAHO dietary survey revealed that as Latin American countries emerge 
from poverty, there is an increasing trend in obesity, especially in urban settings [10]. 
In contrast, in the middle income countries of the region, obesity is seen to decrease 
as incomes rise, especially among women. The increased obesity rates are explained 
by dietary changes and increased inactivity, especially among low-income groups 
who improve their incomes but predominantly buy high fat, high carbohydrate and 
energy-dense foods [10]. The increased intake of these foods is detrimental to the 
intake of grains, fruits and vegetables in the same population groups. Most of these 
region’s aboriginal populations seem to have changed their dietary habits and physical 
activity to fit industrialized country models; they indulge in Western fast foods, and 
lead sedentary and physically inactive lifestyles. With this trend, the rates of obesity, 
insulin resistance and type 2 diabetes are observed to be on the rise [10]. The rates 
were high among women, especially those with little schooling, and occurred more 
frequently in poorer households [11]. The authors attributed the rise in obesity to 
infant and foetal nutritional malnutrition, inadequate or lack of education and socio-
economic conditions, dietary changes towards energy dense foods and physical 
inactivity.  
 
The WHO points out that under-nutrition in the foetal stage and in infancy 
predisposes one to obesity in older age where socio-economic conditions favour it [9]. 
Although childhood obesity is as common in Russia as in the US, Russians seem to 
lose weight as they approach adulthood [12]. In a nationally representative study of 
Russian adults, aged between 19 and 55 years in the first 8 years of the Russian 
Federation’s transition to a market economy, it was found that overweight remained 
fairly stable over the period at 50%, while obesity increased from 13.3 to 16% in the 
adult population [12].  
 
The Food Standards Agency of the UK gave published data for obesity (%) (females 
vs. males) in some countries from 1999-2000 as follows: the Russian Federation (25 
vs. 10), Mexico (25 vs. 15), Argentina (25 vs. 28), France (7 vs. 8), the UK (24 vs. 
21), Germany (19 vs. 17), Italy (9.9 vs. 9.5), Spain (15 vs. 12) [13]. However, these 
estimates may have changed over the period after the date.  
 
The WHO estimated that adult BMI of 22-23 were prevalent in most countries of 
Africa and Asia, while BMI of 25-27 were prevalent in North America, Europe and 
parts of Latin America, North Africa and some Pacific Island countries [14]. It 
estimated that obesity rates vary from below 5% in China, Japan and certain African 
countries to over 75% in urban Samoa. However, in China, rates were as high as 20% 
in some cities, similar to cities in the developed world [14]. The rates of the epidemic 
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Regional levels of obesity 
The US has the highest rates of obesity among developed countries (32%), in the 
adult population [14]. The rates vary with gender and ethnicity. It is higher in women 
than men (35 versus 33%), similar to other regions of the world. In the US, the 
scourge is higher among African-Americans than other races [15]. In Canada, the 
aboriginals tend to be more obese than the Caucasian groups [15]. Due to the dramatic 
rise in Class III obesity, more than 30% of annual deaths in the US are reported to be 
associated with obesity related ill-health complications [15].  
 
In a sample of 7786 women aged 19-95 years old in South Africa, black women had 
the highest prevalence of overweight and obesity (58.5%), followed by women of 
mixed ancestry (52%), white women (49.2%) and Indian women (42.8%) [16]. Urban 
women had higher BMI than their rural counterparts and in both groups, BMI 
increased with age. Central obesity (defined by cut-off points for waist to hip ratio of 
0.85 for women and 1.0 for men) was higher among urban African women (42%) and 
was most prevalent in African women and among women of mixed race [16]. The 
overall prevalence of obesity and overweight in South Africa is high, with 29% of 
men and 56% of women being classified as overweight or obese. This is higher than 
reported in other African countries, particularly among women, since 30% of South 
African women aged between 30 and 59 were reported obese [16]. The other African 
region where obesity rates are as high as in South Africa is North Africa [14].  
 
In a cross-sectional study among the Luo, Maasai and Kamba, in rural and urban 
Kenya, among 1430 individuals (58.3% females), aged 17-68 years, abdominal 
visceral and subcutaneous fat, arm fat area (AFA), and waist circumference increased 
with age and were highest among the Maasai and in urban populations [17]. AFA 
increased only with increasing age among males. The prevalence of overweight (BMI 
≥25) and obesity (BMI ≥30) was higher in Kenyan urban compared to the rural 
populations studied (39.8% vs. 15.8%) [17]. Abdominal visceral and subcutaneous fat 
thickness was highest with urban residency. In this Kenyan study, a high prevalence 
of overweight and obesity was found with the highest fat accumulation among the 
Maasai [17]. The mean Kenya national prevalence rate was estimated as 13% in 2004 
[18].  
 
In Asia, India, China, Indonesia, Japan and Bangladesh are listed among the WHO’s 
10 countries with the greatest prevalence of obesity. In India, morbid obesity in the 
21st century has reached 5% of the country’s population, while in Chinese cities, 12% 
of adults and 8% of children were reported obese [14]. 
 
The obesity outlook in Africa 
In West Africa, the rate of obesity is about 10% [14]. It is 3x higher among women 
than men. In parts of West Africa, the rates have more than doubled in the last 15 
years [14]. In South Africa one in 3 men and one in 2 women are either overweight or 
obese [16]. These South African statistics are close to the figures for the US. In 
Morocco, the rate of obesity is estimated to be 40% in the general population, while it 
is estimated to be about 12% in Kenya [17]. However, the most worrying trend is 
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other developing countries. In Nigeria, it is estimated that about 6-8% of the 
population is obese [19]. It is opined that the increasing consumption of processed and 
high fat fast foods, frequent snacking while watching movies and lack of regular 
exercise are contributing to the rise of the scourge. Zizza and others reported that 
between 1978 and 1996, there was a significant proportion of young adults snacking, 
representing a case for concern worldwide [20]. The lack of space for sports grounds 
and facilities in African cities is contributing to the rise in rates of the epidemic in 
urban areas. The habit of families sitting for long hours watching TV, videos and 
children playing video games for long, is also likely to contribute to the rising rates of 
obesity and overweight among affluent and middle class urban dwellers. The 
prevalence rates of obesity in select African countries was 13, 14 and 15% in Sudan, 
Egypt and Libya (North Africa), 15, 10 and 9% in Ghana, Senegal and Niger (West 
Africa), and 13, 12 and 14%, respectively, in Kenya, Uganda and Tanzania in East 
Africa [18].  
 
CAUSES AND AETIOLOGY OF OBESITY 
 
Obesity is the result of an incorrect energy balance leading to an increased store of 
energy, mainly as fat. Overweight and obesity can impair health. The two types of fat 
depositions are sub-cutaneous and visceral. High visceral fat deposition is normally 
associated with elevated plasma low-density lipoprotein (LDL) cholesterol, which in 
turn may lead to hypertension, diabetes, heart disease and stroke [21]. Although 
women tend to be more obese than men, their fat type is predominantly the sub-
cutaneous than the abdominal type before they reach menopause; this seems to reduce 
their susceptibility pre-menopause to hypertension, increased LDL-cholesterol and 
type 2 diabetes than men [21]. On the other hand, visceral fat is associated with fat 
deposition in the middle of the body. In a study [22], the level of active testosterone 
and to a smaller extent, estradiol (the main form of estrogen) in women seemed to be 
linked to the level of visceral fat in the body as evidenced by CT scans. The same 
study also showed that a woman’s age did not correlate significantly with the amount 
of visceral fat, nor did race or other cardiovascular factors. However, other studies 
seemed to show that age and race influence the tendency to obesity [23, 24].  
 
Despite the negative connotations associated with adiposity, adipocytes (fat cells) are 
vital to human health as much as the heart, kidneys and liver are. Adipose tissue 
exerts important endocrine and immune functions through the release of adipokines, 
which regulate adipose tissue metabolism and are associated with alterations in 
insulin resistance [25]. It seems that both overall and central obesity are significantly 
associated with irregular menstrual cycle events and this appears to be mediated by 
hormonal factors particularly testosterone, sex hormone binding globulin and insulin 
[26]. Age, the change in the location of fat deposits, the size and total amount of 
adipocytes may explain the change in the shape of women after menopause. During 
this phase of life, estrogen, the hormone that governs the female monthly cycle 
diminishes, leading to fat migration from the hips, arms and thighs to the abdomen, 
and is hypothesized to lead to higher susceptibility of post-menopausal women to 
cardiovascular disease and type 2 diabetes than their younger counterparts [27]. Also, 
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incidence of type 2 diabetes in women, in later life [28]. Post-menopause, 
progesterone production diminishes in addition to estrogen decline, leading to the 
need for the body to produce more of both hormones; this occurs by the deposition of 
more fat cells in the thighs, hips and breasts. The decline in progesterone level leads 
to the retention of greater amount of body fluid, which is manifest as weight gain. Fat 
is therefore at the centre of a very complex system which coordinates several body 
functions, but whose excess deposition can impair human health.  
 
Generally, obesity is associated with over-nutrition, low physical activity, change of 
dietary habits, urbanization, modernization, the socioeconomic class and in a minority 
of patients to a physical condition or metabolic disturbance [15]. High calorie intake, 
high consumption of fatty meats and oily foods, and high alcohol consumption 
combined with low physical activity are likely to lead to obesity. Habitual, high 
alcohol consumption and other habitual indulgences contributing energy in excess of 
physiological requirements may result in visceral fat deposition. The change of leisure 
activities to those that require low energy expenditure may also lead to adiposity and 
therefore potential obesity. Aging results in slowing metabolism and reduced physical 
activity, resulting in weight gain, which if not watched predisposes to obesity [21].  
 
Other factors influencing obesity 
Generally, eating to the extent inappropriate with one’s physical activity seems to be 
the direct cause of obesity. Obesity is thus a behavioural disorder that is classifiable as 
a psychiatric disorder [21]. Cultural factors also seem to influence the tendency to 
obesity [29]. In a social study in South Africa, moderate obesity in African women 
made them admirable to the menfolk [30], while the Sumo wrestler in Japan requires 
some degree of overweight, not all being muscle.   
 
Adolescents tend to eat more than adults, while boys may eat more than girls. 
Individuality also affects food intake and therefore the tendency to adiposity and 
potential obesity. Many other seemingly unconventional factors are currently being 
considered as contributing to obesity. These include “sleep debt” (sleeping less than 
one should), pollution due to the many chemicals in the environment, which can 
affect hormonal balance and may influence obesity, as hormones control body weight 
[31]. Normally, being in a hot or very cold environment encourages the burning of 
calories. However, being in an air conditioned environment reduces calorie 
utilization. Many drugs including contraceptives, steroid hormones, diabetes drugs, 
some antidepressants and blood pressure drugs may cause undue weight gain. It is 
also emerging that giving birth when older, may carry the risk of the child being obese 
[31]. Marriage of obese couples may lead to obesity in the next generation [31].  
 
Genetic defects, endocrine factors, trauma and obesity 
In man, obesity seems to run in families, but it may be difficult to separate genetic 
from environmental factors [32]. There are rare genetic disorders such as Prader-Willi 
Syndrome in which obesity is a clinical feature. This syndrome is characterized by 
muscle hypotonia, mental retardation, diabetes and obesity [33]. Obesity frequently 
accompanies hypothyroidism, hypogonadism, hypopituitarism and Cushing’s 
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in women obesity commonly begins at puberty, during pregnancy or at menopause 
suggests an endocrine link. Yet the overwhelming majority of obese patients show no 
clinical evidence of an endocrine disorder and the function of their endocrine glands 
may be normal on routine testing. Newer tests may show yet undiscovered, small, but 
probably important deviations in endocrine or metabolic functions that may lead to 
obesity. Although generally uncommon, obesity may follow damage to the 
hypothalamus and its connections after a head injury or other localized lesion. It has 
been reported that lesions of the ventromedial nucleus of the hypothalamus induce 
increased food intake, an action that may lead to obesity where other contributing 
factors exist [34].   
 
EFFECTS OF OBESITY ON HUMAN HEALTH 
 
Obesity is a multifactorial disease. It occurs at all ages and commonly affects the 
health of infants, adolescents and the elderly. Even being overweight seems to 
predispose one to type 2 diabetes, hypertension, stroke, heart attack, congestive heart 
failure and several cancers (mainly colorectal and prostate) [35]. Most obese patients 
are observed to have decreased glucose tolerance, decreased sensitivity to insulin, 
decreased production of ketone bodies during starvation, and decreased sensitivity to 
growth hormones, while showing increased plasma insulin, plasma free fatty acids, 
plasma triglycerides, plasma cholesterol, plasma uric acid, and urinary 17-
hydroxycorticoids [36, 37]. These metabolic changes are probably a result of obesity 
and not its cause. Obesity is associated with macrophage infiltration and with both 
hyperplasia and hypertrophy of adipocytes, which often leads to the chronic disease-
prone state of such patients [38]. However, the most significant metabolic changes 
related to obesity are decreased glucose tolerance, decreased sensitivity to insulin and 
increased plasma insulin [37, 39]. Hyperinsulinaemia is thus an important change that 
is probably due to inadequate feedback inhibition of insulin secretion or reduced 
numbers of insulin receptors associated with obesity [39]. Many obese people may 
therefore be in a pre-diabetic state. Other obesity-associated observations include 
reduced life expectancy and strenuous exercise intolerance [40]. Exercise intolerance 
is evident as shortness of breath on exertion and fatigue on continuing physical 
activity. This may be due to the burden of the increased weight and a reduced capacity 
of the circulatory and respiratory systems that work under handicaps imposed by the 
masses of internal fat and fat infiltration of muscle. These latter observations are 
found in class II and III obesity. Such patients are at risk of a number of metabolic 
disorders including diabetes, hypertension, gall bladder diseases, fatty liver, gout, 
pulmonary disorders, osteoarthritis, hernias (diaphragmatic and abdominal), varicose 
veins and intertriginous dermatitis [36, 21]. Mortality rates increase with increasing 
weight and life expectancy may be reduced [41, 42]. When operated upon, obese 
patients are under increased risk of death when under anesthesia; surgical operations 
on them are difficult and are often accompanied by post-operative complications [41]. 
Daily activities of Class III obese patients are severely restricted by their enormous 
mass; they are also likely to suffer from serious psychological disturbances [21]. This 
may justify the application of cognitive-psychological therapies for their treatments 
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CONTROL AND TREATMENTS OF OBESITY  
 
Treatment of the disease is simple in principle. If a patient eats a diet that provides 
500-1000 Kcal (1-4 MJ) less than  is needed for the activities of daily life, then and 
only then will the excess reserves of energy in adipose tissue be drawn upon and 
weight lost at a rate of 0.5-1 kg each week [21]. However, in practice, this is difficult 
for most patients, since it requires changes in long established habits with a new 
discipline, similar to that which an athlete imposes on herself when going into 
training.  
 
Physical exercise and dietary advice  
Besides restricting food intake, physical fitness should be improved by engaging in as 
much exercise as possible in order to lose weight, but also to maintain the appropriate 
weight in the long-term [43]. Exercise may prove difficult for many patients in the 
early phase of rigorous exercises they may not be accustomed to. Only with strong 
motivation maintained over long periods can patients lose weight and sustain the loss.  
Doctors, dieticians and mutual exchanges in slimming clubs can provide the support 
for morale. Although exercise can help reach a target weight, dietary restriction and 
control are more effective as part of treatment of obesity [43]. Obese patients are 
advised to walk, when possible, rather than use their cars or public transport, to climb 
stairs rather than use the elevator and to take up one or more hobbies demanding 
physical exercise. Hobbies that are suitable for the middle aged and elderly 
demanding physical exertion include dancing, swimming, jogging, golf and 
gardening. Even if exercise contributes only little to a negative energy balance, it 
benefits by promoting physical fitness, and preventing muscle atrophy. Insufficient 
use of the muscles of the trunk and limbs of the respiratory system and of the 
myocardium increases the risk of orthopaedic, respiratory and circulatory disorders 
[21]. In women, planned loss of weight after menopause seems to reduce the risk of 
breast cancer [44]. Patients also require practical advice on food and health based on 
hard science, and, not on false ideas of no practical value which often circulate 
widely, and can be taken readily by despairing patients. It is advisable to set a target 
weight and a realistic time to reach this target. This should be agreed upon between 
the patient and the adviser at the start of treatment. Once the target has been fixed, 
progress should be monitored and checked regularly by weighing and BMI 
calculation [21]. Dietary advice has to be tailored to the patient’s previous food 
history which should be obtained in as much detail as possible. Due to their high 
energy density, it is advisable to remove from diets such high calorie items as refined 
sugar, sweets, candies, jams, jellies, honey, syrups, canned or frozen fruits (unless 
preserved without sugar), dried fruits, cakes, ice cream, fatty meats, sausages, fatty 
fish, fried foods, mayonnaise and salad dressings, cream sauces, carbonated 
beverages, beers, spirits and all alcoholic beverages generally [45]. It is also 
reasonable not to miss any normal meal in the patients’ dietary history to avoid over-
snacking with “junk” foods between meals. However, there is a possibility that any 
curtailment of food intake can reduce the intake of essential nutrients. To avoid such 
eventualities, all food regimes should include ample fruit and vegetable helpings to 
supply vitamins, minerals and dietary fibre [21]. Their ample inclusion also promotes 
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haemoglobin or an iron supplement should be provided. It is important that patients 
do not reduce their dietary energy below 1000 kcal/day except on medical advice and 
with close supervision [45]. If dietary intake is below 1000 kcal/day, excessive losses 
of potassium and nitrogen may occur and patient urinary outputs should therefore be 
checked regularly [21]. During therapeutic total starvation, the urinary nitrogen 
excretion can be reduced from the usual level of 6-8 g/day by giving DL-3-
hydroxybutyrate (18 g/day) and this was observed to be more effective in sparing 
protein than a similar dose of glucose [46]. The administration of the drug did not 
affect weight loss, but seemed to increase the fat/lean ratio of the tissue lost [46]. 
Diets providing ≤ 500 kcal/day or a period of total starvation may be justifiable in 
some patients (Class III obese) who are not responding well to less rigorous 
restrictions [21]. However, close medical supervision is necessary. Only with selected 
patients with no orthopaedic or cardiovascular complications is it possible to increase 
physical activities [21].   
 
Tested and potential drugs for treating obesity 
Amphetamine and its derivatives have been used as “slimming agents”. They are 
psychomotor stimulants and have an anorectic action. They may aid patients adhere to 
their diets, but it is not justifiable to use them at the start of treatment [21]. By 
stimulating higher cortical centres, they may overcome feelings of fatigue, depression, 
and create a sense of well being. However, they may cause insomnia, increase heart 
rate, raise blood pressure and severe psychotic reactions, besides creating dependency 
in a majority of patients [47, 21]. Serious withdrawal symptoms occur on 
discontinuing the drug and therefore amphetamine should not be prescribed for obese 
patients. Generally, anorectic drugs should never be a substitute for a dietary regime 
and radical alteration of food habits. Thyroxine stimulates metabolism and therefore 
has had extensive trials in the treatment of obesity. However, because it is 
contraindicated, except in those cases where obesity is associated with evidence of 
hyperthyroidism, it is not recommended for obesity treatment [21]. Its administration 
is not only dangerous for euthyroid elderly patients with myocardial weakness, but 
also useless as it does not increase metabolism unless applied in large doses that cause 
tremor, diarrhoea, palpitation and tachycardia [47]. Sedatives and tranquilizers may 
only be useful for obese patients who suffer from an anxiety state [47, 48]. Diuretics 
are potentially dangerous, but may be useful where the patient has oedema arising 
from cardiac failure or other organic disease [48]. Other drugs and materials which 
though available (often by non-subscription) for obesity treatment are not effective 
include ephedrine, chitosan, St. John’s wort, hydroxycitric acid, herbal laxatives and 
diuretics, appetite depressants, and 5-hydroxytryptophan [3].  
 
Surgical treatment of obesity 
Surgical interference with the gastrointestinal tract aiming at reducing food intake, 
may be considered in patients in whom medical treatment as discussed in earlier 
chapters has failed, and whose life has been made miserable by severe obesity. 
Various forms of jejunoileostomy which by creating a bypass of the small intestine, 
lead to malabsorption, have been tried [21]. Food intake has often to be reduced to 
prevent flatulence, diarrhoea and abdominal discomfort [21]. The operation seems 
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related to malabsorption and the blind loop syndrome, such operations are seldom 
carried out. An alternative approach is to reduce the size of the stomach, potentially 
forcing the patient to reduce food intake. Gastroplasty is an operation in which the 
stomach is reduced to a small reservoir, about 60 mL in capacity, in the fundus, which 
drains through a narrow channel, about 12 mm in diameter, a long the greater 
curvature and into the duodenum [49]. Although the weight loss was not much 
different from that of controls, those who had vertical banded gastroplasty (VBG) 
were able to maintain their weight loss better and for longer than gastric bypass 
operation [50]. Operations to reduce the size of the stomach seem safer and less 
unphysiological than those that restrict access of food to the small intestine. This is 
more so for the vertical banded gastroplasty-Roux –en-Y gastric bypass (VBG-RGB) 
technique, which is a preferred operation in weight loss surgery [50]. The application 
of adjustable gastric bands seems more humane and physiologically tolerable than the 
practically irreversible resection and by-pass operations [51]. Wiring the jaws with a 
dental splint is another procedure that is aimed at reducing food intake [21]. The 
patient can drink and speak, but not eat. Food intake is limited to liquid foods of low 
energy density. However, when the jaws are unwired, patients return to former eating 
habits and regain weight [21]. Removal of masses of fat from the stomach, thighs and 
arms is contraindicated; the appearance of irregular and ugly lumps of fat at the 
operation sites has been observed [21]. Based on lessons learnt from operations with 
lesions made in the hypothalamus of rats, with the aim of producing aphagia, 
neurosurgeons aim to induce aphagia in humans with the hope that the problem of 
intractable obesity can be explored using stereotatic techniques [52]. Other procedures 
include laparoscopic metabolic surgery and bio-enteric intragastric balloon 
implantation [53]. These techniques may be favored because they are simple to use 
and are less invasive.  
 
SOME POTENTIAL AREAS FOR RESEARCH  
 
A number of potential research areas in connection with obesity include:    
1. Finding better and more accurate methods and procedures and/or improving the 
accuracy of current methods of estimating obesity in individuals  
2. Finding more accurate methods of estimating fat percentage in individuals 
3. Accurately distinguishing overweight due to excess fat deposition and that due 
to muscle atrophy 
4. Finding methods of surgery that are less invasive, are simple to use and result in 
less post-operative complications 
5. Helping patients to re-socialize and improve the quality of life especially after 
surgery using various psycho-social and cognitive therapies 
6. Working on effective pharmacotherapy-based reduction of post-operative 
complications 
7. Finding drugs that have less side effects than those currently used especially in 
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8. To confirm the potential link between foetal malnutrition  or under-nutrition and 
predisposition to obesity in adulthood 





Obesity results from over-nutrition, low physical activity, change of dietary habits, 
urbanization, and in a minority of patients to a physical condition or metabolic 
disturbance. To treat obesity, restricting food intake and engaging in physical fitness 
are necessary. Although exercise can help a patient reach a target weight, dietary 
restriction and control may be more effective for the treatment of obesity. Several 
forms of surgical procedures can be used where exercise and food restriction have 
failed, especially in morbid obesity. However, surgeries may be more expensive and 
carry with them certain uncertainties and problems than dietary plans combined with 
regular physical activity. It seems that society needs to instill in young people healthy 
and orderly eating habits based on sound nutritional science and to provide sports 
fields and the opportunities, education, encouragement and the motivation to use them 
on a regular basis. Exercise and sensible eating are the best ways to regulate body fat 
percentage [54]. Nevertheless, the key to keeping a healthy body weight is largely 
dependent on one’s lifestyle. Despite lower rates of obesity than many regions of the 
world, obesity is increasing in Africa with rates in South Africa and North Africa 
being comparable to those in developed countries. African countries should therefore 





Although obesity may run in families, the key to maintaining a healthy body weight is 
sensible eating based on sound nutritional science and an active lifestyle. As it is 
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